The company
About
Torpedo
Torpedo Pharmaceuticals AG is a Swiss biotech developing next-generation RLT therapies for cancer treatment, with an early focus on advanced prostate cancer.
Torpedo Pharmaceutical AG is a subsidiary of Swiss Rockets AG, one of Switzerland’s leading biotech incubators and accelerators.
About
Torpedo
Torpedo Pharmaceuticals AG is a Swiss biotech developing next-generation RLT therapies for cancer treatment, with an early focus on advanced prostate cancer.
Torpedo Pharmaceutical AG is a subsidiary of Swiss Rockets AG, one of Switzerland’s leading biotech incubators and accelerators.
Science
at the core
Driven by
Innovation
Leadership
excellence
TORPEDO Pharmaceuticals AG's PIPELINE:
TORPEDO Pharmaceuticals AG's
PIPELINE:
TRP-001
161Tb-PSMA targeting early-stage prostate cancer
patients
*The timelines and other projections presented herein are subject to
scientific, economic, business, and financial factors that cannot be
predicted with certainty in advance. Therefore, actual timelines and
outcomes may differ from those projected.
*TRP-001 will be studied as a
single agent and in proprietary combination therapy.
TRP-002
Cyclic peptide targeting various cancers
TRP-003
Diabody targeting various cancers
TRP-004
161Tb-FAPi for various cancers
Download Our
Company Presentation
your name
your email
organization name